English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

The report by Dr Chen and colleagues, published in this issue of Circulation , “Cardiomyocyte-Specific Deletion of the Vitamin D Receptor Gene Results In Cardiac Hypertrophy,” is important and timely.1 This study extends and supports other studies that have demonstrated that vitamin D and the vitamin D receptor (VDR) signaling system possess antihypertrophic activity in the heart. The study also furthers our knowledge of this action by demonstrating an involvement of the prohypertrophic calcineurin/nuclear factor of activated T-cells/modulatory calcineurin-interacting protein-1 pathway. Thereby, they identify a potential mechanism to account for the reported beneficial effects of vitamin D on the cardiovascular system. To respond to the question posed in the title of this editorial, “Is the heart a drugable target for vitamin D receptor agonists?” Chen et al's report makes an affirmative response more plausible.Article see p 1838The first studies to demonstrate a connection between cardiovascular homeostasis and vitamin D status used the established rat model of vitamin D deficiency.2–4 The notion of an involvement of the vitamin D endocrine system with cardiovascular function began >25 years ago by our identification of the VDR in rat cardiac myocytes, and this led us to the physiological studies to establish relevance.5 These animal studies established a connection between vitamin D deficiency and cardiovascular dysfunctions, including cardiac hypertrophy, fibrosis, hypertension, and the elevation of serum calcium, parathyroid hormone, and renin levels. These reports supported a role for vitamin D in maintaining cardiovascular homeostasis through both the direct action of 1,25-dihydroxyvitamin D on cardiomyocyte VDR and indirect actions on circulating hormones and calcium. Our studies in rats maintained on a vitamin D-deficient diet revealed that ventricular muscle mass and contractile function were both markedly enhanced. Increased systolic blood pressure, renin levels, hydroxyproline, and serum creatine phosphokinase were reported, …

Selective Knockout of the Vitamin D Receptor in the Heart Results in Cardiac Hypertrophy